The Unitaid Plus Project looks forward to participating in the 74th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), from November 9th – 13th. We are proud to present poster presentations highlighting the innovations, strategies, and lessons learned generated by activity in project-supported countries: Benin, Cameroon, Côte d’Ivoire, and Mozambique. We are also thrilled to co-host a symposium with Malaria Consortium about lessons learned implementing PMC across Benin, Cameroon, Cote d’Ivoire, Mozambique, and Nigeria.
See below for a full list of our submissions and follow us on LinkedIn for updates throughout the week.
Scientific Symposium
(105) Results from large-scale implementation of perennial malaria chemoprevention (PMC) in Benin, Cameroon, Côte d’Ivoire, Mozambique and Nigeria
Tuesday, November 11 at 4:00 PM Eastern
Convention Center – Room 718B (Level 7)
.
Oral Presentations
(6090) Innovations in mobile data capture for multi-country implementation of a longitudinal malaria chemoprevention study in Cameroon and Cote d’Ivoire
Session: 27 – Global Health: Improved Health Care Service Delivery and Health Systems Strengthening
Monday, Nov. 10th at 10:55 AM Eastern
Convention Center – Room 801A (Level 8)
(7167) Barriers to Essential Programme on Immunisation Coverage and Implications for Perennial Malaria Chemoprevention in Infants: Evidence from census surveys in Cameroon and Côte d’Ivoire
Session: 92 – Global Health: Women’s, Maternal, Newborn, Child, and Adolescent Health
Tuesday, Nov. 11th at 2:55 PM Eastern
Convention Center – Room 801A (Level 8)
(7190) Geographical Variation in Sulfadoxine-Pyrimethamine Resistance Markers and Implications for Malaria Chemoprevention in Cameroon
Session: 98 – Malaria – Current Trends in Antimalarial Drug Resistance
Tuesday, Nov. 11th at 4:10 PM Eastern
Convention Center – Room 701B (Level 7)
.
Poster Presentations
(6315) Surveillance of antimalarial resistance markers to inform SP suitability for perennial malaria chemoprevention in Côte d’Ivoire
Monday, Nov. 10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6317) Mapping antimalarial drug resistance markers in Plasmodium falciparum isolates across Benin
Monday, Nov.10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6393) Social determinants of health and the risk of malaria infection in a cohort study of perennial malaria chemoprevention in Cameroon: A causal mediation analysis
Monday, Nov.10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6402) Health Worker Perceptions of Malaria Vaccine and Perennial Malaria Chemoprevention Co-implementation
Monday, Nov. 10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6411) Do three additional PMC doses affect uptake of vitamin A supplementation in Cameroon? A novel comparative-interrupted time series analysis
Monday, Nov. 10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6416) Integrating evidence from novel chemoprevention trials to estimate protective efficacy of sulfadoxine-pyrimethamine against malaria parasites across different sub-Saharan Africa resistance profiles.
Monday, Nov. 10th at 12:30 PM Eastern
Poster Session A
Convention Center – Hall E (Level 8) (Poster Hall)
(6710) An interactive user-editable web-based app to inform context-adapted, cost-effective policy choices in heterogeneous settings: The perennial malaria chemoprevention decision support tool.
Tuesday, Nov. 11th at 12:00 PM Eastern
Poster Session B
Convention Center – Hall E (Level 8) (Poster Hall)
(6877) Prevalence of Pfdhps and Pfdhfr genetic markers associated with antimalarial drug resistance in two temporal cohorts in the Democratic Republic of Congo and implications for chemoprevention
Tuesday, Nov. 11th at 12:00 PM Eastern
Poster Session B
Convention Center – Hall E (Level 8) (Poster Hall)
(6880) Nationwide Surveillance of Molecular Markers of Antimalarial Resistance in Ghana
Tuesday, Nov. 11th at 12:00 PM Eastern
Poster Session B
Convention Center – Hall E (Level 8) (Poster Hall)
(6961) The secondary benefits of providing malaria chemoprevention to infants and children
Tuesday, Nov. 11th at 12:00 PM Eastern
Poster Session B
Convention Center – Hall E (Level 8) (Poster Hall)
(6983) Reaching children in the second year of life with perennial malaria chemoprevention (PMC): Opportunities and challenges from Benin, Côte d’Ivoire and Cameroon
Tuesday, Nov. 11th at 12:00 PM Eastern
Poster Session B
Convention Center – Hall E (Level 8) (Poster Hall)
(7471) Emergence of a validated Plasmodium falciparum Kelch 13 mutation (A675V) associated with artemisinin partial resistance and low prevalence of pfhrp2/3 deletions in Cameroon
Wednesday, Nov. 12th at 11:00 AM Eastern
Poster Session C
Convention Center – Hall E (Level 8) (Poster Hall)
(7566) Time from asymptomatic malaria infection to onset of symptoms in retrospective PCR analysis of samples collected among children over 63 days: Evidence from two randomised placebo-controlled trials of malaria chemoprevention in Zambia and Cameroon
Wednesday, Nov. 12th at 11:00 AM Eastern
Poster Session C
Convention Center – Hall E (Level 8) (Poster Hall)
(7571) Implementation of perennial malaria chemoprevention in Cameroon: coverage, equity of coverage and change in coverage of co-interventions
Wednesday, Nov. 12th at 11:00 AM Eastern
Poster Session C
Convention Center – Hall E (Level 8) (Poster Hall)
(7577) Implementation of perennial malaria chemoprevention in Benin and Cote d’Ivoire: what are the determinants of co-delivery of doses with childhood vaccinations in the first and second years of life?
Wednesday, Nov. 12th at 11:00 AM Eastern
Poster Session C
Convention Center – Hall E (Level 8) (Poster Hall)